-
Signature
-
/s/ Nisha Antony, as Attorney-in-Fact
-
Issuer symbol
-
CRWV
-
Transactions as of
-
09 Feb 2026
-
Net transactions value
-
-$3,198,377
-
Form type
-
4
-
Filing time
-
11 Feb 2026, 20:56:26 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| McBee Brannin |
Chief Development Officer |
C/O COREWEAVE, INC., 290 WEST MT. PLEASANT AVENUE, SUITE 4100, LIVINGSTON |
/s/ Nisha Antony, as Attorney-in-Fact |
11 Feb 2026 |
0002058103 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CRWV |
Class A Common Stock |
Conversion of derivative security |
|
+25,000 |
|
|
25,000 |
09 Feb 2026 |
Canis Major 2025 GRAT |
F1, F2 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$18,070 |
-202 |
-0.81% |
$89.45 |
24,798 |
09 Feb 2026 |
Canis Major 2025 GRAT |
F2, F3, F4 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$5,622 |
-62 |
-0.25% |
$90.67 |
24,736 |
09 Feb 2026 |
Canis Major 2025 GRAT |
F2, F3, F5 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$31,799 |
-345 |
-1.4% |
$92.17 |
24,391 |
09 Feb 2026 |
Canis Major 2025 GRAT |
F2, F3, F6 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$27,417 |
-295 |
-1.2% |
$92.94 |
24,096 |
09 Feb 2026 |
Canis Major 2025 GRAT |
F2, F3, F7 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$111,656 |
-1,186 |
-4.9% |
$94.15 |
22,910 |
09 Feb 2026 |
Canis Major 2025 GRAT |
F2, F3, F8 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$583,216 |
-6,125 |
-27% |
$95.22 |
16,785 |
09 Feb 2026 |
Canis Major 2025 GRAT |
F2, F3, F9 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$796,615 |
-8,291 |
-49% |
$96.08 |
8,494 |
09 Feb 2026 |
Canis Major 2025 GRAT |
F2, F3, F10 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$789,684 |
-8,140 |
-96% |
$97.01 |
354 |
09 Feb 2026 |
Canis Major 2025 GRAT |
F2, F3, F11 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$34,586 |
-354 |
-100% |
$97.70 |
0 |
09 Feb 2026 |
Canis Major 2025 GRAT |
F2, F3, F12 |
| transaction |
CRWV |
Class A Common Stock |
Conversion of derivative security |
|
+8,335 |
|
|
8,335 |
09 Feb 2026 |
Canis Minor 2025 GRAT |
F1, F13 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$6,083 |
-68 |
-0.82% |
$89.46 |
8,267 |
09 Feb 2026 |
Canis Minor 2025 GRAT |
F3, F4, F13 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$1,814 |
-20 |
-0.24% |
$90.68 |
8,247 |
09 Feb 2026 |
Canis Minor 2025 GRAT |
F3, F5, F13 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$10,599 |
-115 |
-1.4% |
$92.17 |
8,132 |
09 Feb 2026 |
Canis Minor 2025 GRAT |
F3, F6, F13 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$9,107 |
-98 |
-1.2% |
$92.93 |
8,034 |
09 Feb 2026 |
Canis Minor 2025 GRAT |
F3, F7, F13 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$37,281 |
-396 |
-4.9% |
$94.14 |
7,638 |
09 Feb 2026 |
Canis Minor 2025 GRAT |
F3, F8, F13 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$194,437 |
-2,042 |
-27% |
$95.22 |
5,596 |
09 Feb 2026 |
Canis Minor 2025 GRAT |
F3, F9, F13 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$265,570 |
-2,764 |
-49% |
$96.08 |
2,832 |
09 Feb 2026 |
Canis Minor 2025 GRAT |
F3, F10, F13 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$263,292 |
-2,714 |
-96% |
$97.01 |
118 |
09 Feb 2026 |
Canis Minor 2025 GRAT |
F3, F11, F13 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
$11,529 |
-118 |
-100% |
$97.70 |
0 |
09 Feb 2026 |
Canis Minor 2025 GRAT |
F3, F12, F13 |
| holding |
CRWV |
Class A Common Stock |
|
|
|
|
|
1,800 |
09 Feb 2026 |
See Footnote |
F14 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CRWV |
Class B Common Stock |
Conversion of derivative security |
|
-25,000 |
-0.43% |
|
5,725,000 |
09 Feb 2026 |
Class A Common Stock |
25,000 |
|
Canis Major 2025 GRAT |
F1, F2 |
| transaction |
CRWV |
Class B Common Stock |
Conversion of derivative security |
|
-8,335 |
-0.91% |
|
908,315 |
09 Feb 2026 |
Class A Common Stock |
8,335 |
|
Canis Minor 2025 GRAT |
F1, F13 |
| holding |
CRWV |
Class B Common Stock |
|
|
|
|
|
2,280,300 |
09 Feb 2026 |
Class A Common Stock |
2,280,300 |
|
By Spouse |
F1, F15 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
Remarks:
This Form 4 is Part 3 of 3 for this reporting person. Transactions by the reporting person are continued on this Part 3.